Mirion Technologies, Inc. reports company developments in radiation detection, measurement, analysis and monitoring solutions for nuclear, medical, defense and research markets. Updates commonly cover financial results, orders, guidance, investor presentations and leadership appointments across the Nuclear & Safety and Medical groups.
Mirion's recurring business themes include nuclear power customers, critical radiation safety applications, R&D labs, nuclear facilities and healthcare uses such as Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry and Diagnostic Imaging. News also reflects the completed Paragon Energy Solutions acquisition, which added engineered nuclear-power offerings and is being integrated into the Nuclear & Safety group.
Janus International Group (NYSE: JBI) has appointed David Vanevenhoven as Chief Accounting Officer, effective February 20, 2023. Vanevenhoven, who has over 15 years of experience in accounting and M&A auditing, will directly report to CFO Anselm Wong. He previously served as Global Controller at Mirion Technologies (NYSE: MIR), where he managed multiple acquisitions and a successful SPAC merger. His role at Janus aims to enhance financial reporting and internal controls, positioning the company for continued growth in the self-storage sector. This strategic appointment follows the release of Janus's annual financial results for 2022.
Mirion Technologies, Inc. (MIR) reported a 22.6% revenue increase in Q4 2022, reaching $217.9 million, compared to $177.8 million in Q4 2021. The GAAP net loss was $159.7 million, translating to a loss per share of $0.85. Adjusted EBITDA stood at $56.4 million with adjusted EPS of $0.11. For 2023, the company anticipates revenue growth of 6% to 9% and adjusted EBITDA between $172 million and $182 million. Despite goodwill impairments of $156.6 million, Mirion's order backlog grew to $737.4 million. Management expresses optimism for continued growth driven by healthy end markets and a solid backlog.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at Citi’s 2023 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation is scheduled for 1:50 PM ET on Tuesday, February 21, 2023. A live webcast will be available at Mirion’s investor relations page, with an archived version accessible within twelve hours post-event.
About Mirion: Headquartered in Atlanta, GA, Mirion provides detection, measurement, and analysis solutions across nuclear, defense, medical, and research sectors, employing around 2,800 individuals globally.
Mirion Technologies (NYSE: MIR) will release its financial results for Q4 and fiscal year 2022 on February 14, 2023. A conference call will follow at 10:00 am ET to discuss these results. Participants can join the call by dialing 1-877-407-9208 or 1-201-493-6784, and a live webcast will be available at Mirion's investor website. A telephonic replay will be accessible until February 28, 2023, with details for accessing it provided. Mirion is a leader in detection and monitoring solutions in various end markets including nuclear and medical sectors, employing roughly 2,800 staff across 13 countries.
Mirion Technologies, through its subsidiary Sun Nuclear, has designated Scripps Health as a Patient Safety Center of Excellence. This recognition highlights Scripps' leadership in Quality Management and Medical Physics in Radiation Therapy, with a focus on improving patient safety. Treating approximately 2,700 new patients annually in San Diego, Scripps aims to standardize and automate Quality Management workflows, enhancing efficiency. By leveraging Sun Nuclear's solutions, Scripps will guide other U.S. medical physics departments, thereby contributing to advancements in treatment protocols.
Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the CJS Securities 23rd Annual New Ideas for the New Year Conference on January 11, 2023, at 3:45 PM ET. The presentation will be available via live webcast on their website, with an archive accessible within twelve hours post-event. Mirion specializes in detection, measurement, and monitoring solutions across various sectors, employing around 2,800 people globally.
Mirion Technologies, Inc. (NYSE: MIR) has entered a definitive agreement to sell the physical medicine assets of Biodex Medical Systems, Inc. to Salona Global Medical Device Corporation for $5 million in cash and up to $3 million in deferred cash payments based on asset performance. These assets generated approximately $18 million in revenue with a gross margin of 30% in the last year. The deal is expected to close on December 31, 2022, allowing Mirion to focus on its core mission regarding ionizing radiation.
Mirion Technologies (MIR) reported third-quarter revenues of $160.9 million, an 11.5% increase from $144.3 million year-over-year. Despite this growth, the company faced a GAAP net loss of $50.4 million compared to a loss of $46.7 million in the prior year. Adjusted EBITDA decreased slightly to $30.8 million. Mirion anticipates organic adjusted revenue growth of 4% to 6% for 2022 alongside adjusted EBITDA guidance of $160 million to $170 million and adjusted EPS of $0.37 to $0.41. Year-to-date order growth stood at 23% with a $726 million backlog.
Mirion Technologies (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the 2022 Baird Industrial Conference in Chicago, IL. The presentation is scheduled for 11:50 AM ET on Thursday, November 10, 2022. A live webcast will be available at this link and will be archived for two weeks post-event.
Mirion is a premier provider of solutions for the nuclear, defense, medical, and research sectors, employing around 2,800 people globally.
Mirion Technologies (NYSE: MIR) announced it will release its financial results for Q3 2022 on November 1, 2022, after market close. The company will hold a conference call at 4:30 pm ET on the same day to discuss the results. Interested participants can join the call by dialing 1-877-407-9208 or 1-201-493-6784, or via a live webcast on the company's investor relations website.
Mirion is a leading provider of radiation detection and monitoring solutions, headquartered in Atlanta, GA, and operates in 13 countries with approximately 2,800 employees.